About your former Member of Parliament

Eric Ollerenshaw is a former MP for Lancaster and Fleetwood.

What you can do

• Find out more about your MP, including their voting summary, register of interests and recent speeches.

Profile

Former Conservative MP for Lancaster and Fleetwood

Entered the House of Commons on 6 May 2010 — General election

Left the House of Commons on 30 March 2015 — General election

• Wikipedia page

Social Media

• https://facebook.com/ericollerenshawofficial

Expenses

• Expenses from 2010 onwards

Topics of interest

• Health
• Communities and Local Government
• Education
• Business
• Innovation and Skills
• Environment Food and Rural Affairs
• Departmental Data Protection
• National Curriculum Tests
• Government Procurement Card
• Benzodiazepines
• Departmental Legislation

Other offices held in the past

• Member, Standards and Privileges Committee (26 Jul 2010 to 19 Oct 2010)

Future MPs in this constituency

• Cat Smith

Public bill committees (Sittings attended)

• Enterprise and Regulatory Reform Bill Committee (17 out of 17)
• Prisons (Property) bill Committee (1 out of 1)
• Localism Bill Committee (23 out of 24)
• Terrorism Prevention and Investigation Measures Bill Committee (9 out of 10)

Recent appearances

• Written Answers — Department of Health: Drugs: Poisoning 24 Mar 2015

  To ask the Secretary of State for Health, how many (a) men, (b) women and (c) children were admitted to hospital for drug poisoning, showing ICD10 codes T36-T50 separately, at a four character level in 2014.

• Written Answers — Department of Health: Tranquillisers 24 Mar 2015

  To ask the Secretary of State for Health, whether the General Practice Research Database includes data on the prescribing of tranquillisers; and if he will use this database to calculate the number of patients with a long-term dependency on tranquillisers.

• Written Answers — Attorney General: GlaxoSmithKline 24 Mar 2015

  To ask the Attorney General, whether there is a point of contact for members of the public who wish to help the Serious Fraud Office investigation into GlaxoSmithKline.

More of Eric Ollerenshaw’s recent appearances